United States
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 368.91 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
2 |
USD 330.19 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
3 |
USD 293.96 B
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
4 |
USD 150.41 B
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
|
5 |
USD 149.88 B
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
6 |
USD 87.70 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
7 |
USD 79.93 B
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
8 |
USD 15.04 B
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
9 |
USD 11.36 B
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
10 |
USD 10.59 B
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
11 |
USD 10.06 B
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
12 |
USD 7.43 B
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
13 |
USD 5.64 B
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
14 |
USD 5.15 B
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
15 |
USD 5.00 B
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
16 |
USD 4.76 B
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
17 |
USD 4.40 B
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
18 |
USD 1.39 B
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
19 |
USD 1.24 B
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
20 |
USD 1.06 B
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
21 |
USD 867.01 M
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
22 |
USD 790.38 M
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
23 |
USD 555.46 M
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
24 |
USD 520.49 M
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
25 |
USD 363.09 M
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
26 |
USD 326.72 M
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
27 |
USD 259.34 M
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
28 |
USD 193.06 M
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
29 |
USD 153.52 M
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
30 |
USD 104.67 M
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
31 |
USD 95.21 M
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
32 |
USD 75.48 M
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
33 |
USD 35.35 M
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest Revenue is CVS Health Corporation (NYSE: CVS) at USD 368.91 B.
The Drugstores & Retail Pharmacies company in United States with the lowest Revenue is Biofrontera Inc. (NasdaqCM: BFRI) at USD 35.35 M.
The top 10 Drugstores & Retail Pharmacies companies in United States by Revenue are CVS Health Corporation, McKesson Corporation, Cencora, Walgreens Boots Alliance, Inc., The Kroger Co., Johnson & Johnson, Albertsons Companies, Inc., Viatris Inc., Ulta Beauty, Inc. and BrightSpring Health Services, Inc. Common Stock.
The bottom 10 Drugstores & Retail Pharmacies companies in United States by Revenue are Biofrontera Inc., Aytu BioPharma, Inc., Pilulka Lékárny a.s., ShotSpotter, Inc., AstroNova, Inc., biote Corp., PetMed Express, Inc., Xponential Fitness, Inc., Innoviva, Inc. and Sturm, Ruger & Company, Inc..